Skip to content

    FENNEC PHARMACEUTICALS (FENC) stock price & financials

    View FENC earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+35.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $6.97M
    $7.92M
    $8.75M
    $9.65M
    $12.46M
    +78.7%
    $13.78M
    +73.8%
    $15.11M
    +72.6%
    $17.87M
    +85.2%
    Strengthening
    Operating Profit
    -$5.20M
    -$934.0K
    -$808.0K
    -$2.73M
    -$189.0K
    +96.4%
    -$2.55M
    -173.3%
    -$119.0K
    +85.3%
    $1.74M
    Weakening
    Net Profit
    -$5.74M
    -$1.99M
    -$1.17M
    -$3.15M
    -$638.0K
    +88.9%
    -$4.79M
    -141.1%
    $201.0K
    $1.97M
    Weakening
    EPS
    $-0.21
    $-0.04
    $-0.11
    $-0.02
    +90.5%
    $0.01
    $0.06
    Strengthening
    Other Income
    -$533.0K
    -$686.0K
    -$357.0K
    -$420.0K
    -$449.0K
    +15.8%
    -$2.13M
    -210.1%
    $320.0K
    $278.0K
    Weakening
    Interest
    Depreciation
    Profit before Tax
    -$3.15M
    $2.02M
    MarginsOPM
    -74.6%
    -11.8%
    -9.2%
    -28.3%
    -1.5%
    +98.0%
    -18.5%
    -57.2%
    -0.8%
    +91.4%
    9.7%
    Strengthening
    Tax
    2.1%
    ReturnsROIC
    16.8%
    5.8%
    3.4%
    9.3%
    1.9%
    -88.9%
    14.1%
    +141.1%
    -0.6%
    -117.3%
    -5.8%
    -162.6%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$22.78M$13.65M$30.34M$21.10M$23.77M$13.27M$26.63M$36.79M$41.25M
    Short-Term Investments
    Total Current Assets$22.95M$13.88M$31.42M$22.39M$26.73M$26.86M$44.12M$67.04M$72.50M
    Net PP&E
    Goodwill
    Intangibles
    Total Assets$22.95M$14.15M$31.42M$22.41M$26.94M$26.86M$44.95M$70.55M$75.75M
    LiabilitiesTotal Current Liabilities$1.64M$2.27M$2.35M$1.65M$4.61M$7.55M$6.92M$10.52M$12.39M
    Short-Term Debt
    Long-Term Debt$5.00M$24.90M$30.93M$19.34M
    Long-Term Leases$2.0K
    Total Liabilities$1.64M$2.27M$2.35M$6.64M$29.51M$38.49M$50.82M$35.08M$33.31M
    EquityCommon Stock & APIC$106.39M$106.39M$140.73M$140.80M$142.59M$144.31M$145.61M$189.91M$193.19M
    Retained Earnings-$131.26M-$144.03M-$162.14M-$179.49M-$203.20M-$219.25M-$219.68M-$229.42M-$227.25M
    Total Equity$21.31M$11.88M$29.07M$15.77M-$2.57M-$11.62M-$5.87M$35.47M$42.44M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$7.83M-$9.06M-$15.60M-$14.22M-$18.06M-$17.14M$26.98M-$12.47M-$2.04M
    Cash from Investing$0
    Cash from Financing$2.35M-$71.0K$32.29M$4.98M$20.73M$6.64M-$13.62M$22.63M$24.58M
    SummaryCapital Expenditure
    Free Cash Flow
    FCF Margin

    Ratios